The O
5 O
' O
flanking O
region O
contains O
potential O
binding O
sites O
for O
TATA B
- I
binding I
protein I
, O
Sp1 B
, O
nuclear B
factor I
1 I
( O
NF1 B
) O
, O
CAAT B
- I
box I
binding I
protein I
( O
C B
/ I
EBP I
) O
, O
hepatocyte B
nuclear I
factors I
1 I
and I
5 I
( O
HNF1 B
, O
HNF5 B
) O
and O
activator B
proteins I
1 I
and I
2 I
( O
AP1 B
, O
AP2 B
) O
. O

Neither O
of O
these O
proteins O
, O
individually O
or O
as O
a O
pair O
, O
can O
bind O
the O
alpha B
- I
globin I
3 I
' I
UTR I
unless O
they O
are O
complexed O
with O
the O
remaining O
non O
- O
poly O
( O
C O
) O
binding O
proteins O
of O
the O
alpha B
- I
complex I
. O

The O
galactose B
transporter I
shows O
both O
sequence O
and O
structural O
homology O
with O
a O
superfamily O
of O
sugar B
transporters I
which O
includes O
the O
human B
HepG2 I
- I
erythrocyte I
and I
fetal I
muscle I
glucose I
transporters I
, O
the O
rat B
brain I
and I
liver I
glucose I
transporters I
, O
the O
Escherichia B
coli I
xylose I
and I
arabinose I
permeases I
, O
and O
the O
S B
. I
cerevisiae I
glucose I
, I
maltose I
, I
and I
galactose I
transporters I
. O

The O
galactose B
transporter I
shows O
both O
sequence O
and O
structural O
homology O
with O
a O
superfamily O
of O
sugar B
transporters I
which O
includes O
the O
human B
HepG2 I
- I
erythrocyte I
and I
fetal I
muscle I
glucose I
transporters I
, O
the O
rat B
brain I
and I
liver I
glucose I
transporters I
, O
the O
Escherichia B
coli I
xylose I
and I
arabinose I
permeases I
, O
and O
the O
S B
. I
cerevisiae I
glucose I
, I
maltose I
, I
and I
galactose I
transporters I
. O

A O
developmentally O
modulated O
chromatin O
structure O
at O
the O
mouse B
immunoglobulin I
kappa I
3 I
' I
enhancer I
. O

Vasoactive B
intestinal I
peptide I
and O
pituitary B
adenylate I
cyclase I
- I
activating I
polypeptide I
inhibit O
nuclear B
factor I
- I
kappa I
B I
- I
dependent I
gene I
activation O
at O
multiple O
levels O
in O
the O
human O
monocytic O
cell O
line O
THP O
- O
1 O
. O

To O
determine O
the O
signal B
recognition I
particle I
( O
SRP B
) O
- O
SRP B
receptor I
( O
Srb B
) O
system O
in O
Bacillus O
subtilis O
( O
Bs O
) O
, O
we O
cloned O
the O
Bs B
srb I
gene I
, O
which O
encodes O
a O
homologue O
of O
the O
mammalian B
SRP I
receptor I
alpha I
- I
subunit I
[ O
Oguro O
et O
al O
. O
, O
DNA O
Res O
. O

Also O
, O
the O
human B
glycoprotein I
alpha I
- I
subunit I
promoter I
was O
induced O
10 O
- O
fold O
by O
FSK B
in O
GH4 O
rat O
pituitary O
cells O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

The O
RNA O
- O
binding O
and O
RNA B
- I
DNA I
helicase I
activities O
of O
the O
Escherichia B
coli I
transcription I
termination I
factor I
rho I
have O
been O
investigated O
using O
natural O
RNA O
molecules O
that O
are O
255 O
and O
391 O
nucleotide O
residues O
in O
length O
and O
that O
contain O
the O
trp B
t I
' I
rho I
- I
dependent I
termination I
sequence I
of O
E O
. O
coli O
. O

There O
occurred O
a O
linear O
relationship O
between O
the O
drop O
in O
glucose B
- I
6 I
- I
phosphatase I
dehydrogenase I
activity O
and O
in O
vitamin O
E O
level O
, O
on O
one O
hand O
, O
and O
the O
duration O
of O
poisoning O
with O
sodium O
nitrite O
. O

Full B
- I
length I
AT I
- I
PHH1 I
, O
and O
both O
AT B
- I
PHH1 I
and O
AT B
- I
PHH1 I
delta I
C I
- I
513 I
( O
truncated O
to O
be O
approximately O
the O
size O
of O
microbial B
photolyase I
genes I
) O
cDNAs O
, O
were O
overexpressed O
, O
respectively O
, O
in O
yeast O
and O
Escherichia O
coli O
mutants O
hypersensitive O
to O
ultraviolet O
light O
. O

BACKGROUND O
: O
The O
c B
- I
myc I
proto I
- I
oncogene I
has O
been O
suggested O
to O
play O
key O
roles O
in O
cell O
proliferation O
, O
differentiation O
, O
transformation O
and O
apoptosis O
. O

The O
RAS B
- O
cyclic B
AMP I
- I
dependent I
protein I
kinase I
cAPK B
pathway O
prevents O
the O
UAS O
activity O
of O
IREu B
in O
the O
presence O
of O
glucose O
as O
the O
sole O
carbon O
source O
, O
while O
the O
transcriptional O
activators O
Msn2p B
and O
Msn4p B
promote O
the O
UAS O
activity O
of O
this O
repeat O
in O
the O
presence O
of O
acetate O
. O

Comparison O
of O
the O
amino O
acid O
sequence O
of O
the O
M B
RNA I
product I
of I
Uukuniemi I
virus I
with O
that O
of O
Punta O
Toro O
and O
Rift O
Valley O
fever O
viruses O
showed O
in O
both O
cases O
a O
weak O
homology O
that O
was O
more O
pronounced O
for O
the O
proteins O
located O
at O
the O
COOH O
- O
terminal O
end O
of O
the O
precursor O
. O

Proteins O
known O
to O
bind O
the O
PEPCK B
CRE O
include O
the O
CRE B
- I
binding I
protein I
( O
CREB B
) O
and O
members O
of O
the O
CCAAT B
/ I
enhancer I
- I
binding I
protein I
( O
C B
/ I
EBP I
) O
family O
. O

Quantitative O
evaluation O
of O
the O
steady O
state O
kinetics O
of O
MEK B
inhibition O
by O
these O
compounds O
reveals O
that O
U0126 O
has O
approximately O
100 O
- O
fold O
higher O
affinity O
for O
deltaN3 B
- I
S218E I
/ I
S222D I
MEK I
than O
does O
PD098059 O
. O

The O
predicted O
amino O
acid O
sequence O
of O
m B
- I
Staf I
is O
highly O
homologous O
to O
that O
of O
Staf B
, O
another O
selenocysteine B
tRNA I
gene I
transcription I
activating I
factor I
of O
Xenopus O
laevis O
. O

The O
mechanism O
of O
the O
induction O
of O
3beta B
- I
HSD I
type I
1 I
gene I
expression O
was O
further O
characterized O
in O
ZR O
- O
75 O
- O
1 O
human O
breast O
cancer O
cells O
. O

The O
predicted O
L B
mRNA I
was O
6398 O
nucleotides O
long O
and O
contained O
a O
single O
open O
reading O
frame O
corresponding O
to O
an O
L B
protein I
encompassing I
2109 I
amino I
acids I
with O
a O
MW O
of O
241 O
, O
546 O
. O

A O
gene O
in O
Drosophila O
melanogaster O
that O
maps O
cytologically O
to O
2C1 O
- O
3 O
on O
the O
distal O
portion O
of O
the O
X O
- O
chromosome O
encodes O
a O
member O
of O
the O
steroid B
/ I
thyroid I
hormone I
receptor I
superfamily I
. O

Derepression O
of O
gene O
expression O
mediated O
by O
the O
5 O
' O
upstream O
region O
of O
the O
isocitrate B
lyase I
gene I
of I
Candida I
tropicalis I
is O
controlled O
by O
two O
distinct O
regulatory O
pathways O
in O
Saccharomyces O
cerevisiae O
. O

Retroviral O
transduction O
of O
T B
/ I
T I
( I
L I
) I
causes O
a O
rapidly O
fatal O
myeloproliferative O
disease O
in O
a O
murine O
bone O
marrow O
transplant O
( O
BMT O
) O
model O
, O
whereas O
T B
/ I
T I
( I
F I
) I
causes O
a O
long O
- O
latency O
, O
pre O
- O
B O
- O
cell O
lymphoblastic O
lymphoma O
. O

Retroviral O
transduction O
of O
T B
/ I
T I
( I
L I
) I
causes O
a O
rapidly O
fatal O
myeloproliferative O
disease O
in O
a O
murine O
bone O
marrow O
transplant O
( O
BMT O
) O
model O
, O
whereas O
T B
/ I
T I
( I
F I
) I
causes O
a O
long O
- O
latency O
, O
pre O
- O
B O
- O
cell O
lymphoblastic O
lymphoma O
. O

A O
mouse B
brain I
beta I
- I
spectrin I
of O
cDNA O
was O
identified O
within O
a O
lambda O
Gt11 O
expression O
library O
using O
an O
antibody O
which O
specifically O
binds O
with O
the O
235 B
kDa I
spectrin I
beta I
- I
subunit I
. O

The O
promoter O
for O
HMG B
- I
CoA I
synthase I
contains O
two O
binding O
sites O
for O
the O
sterol B
regulatory I
element I
- I
binding I
proteins I
( O
SREBPs B
) O
. O

Single O
amino O
acid O
substitutions O
at O
the O
acyl O
- O
CoA O
- O
binding O
domain O
interrupt O
14 O
[ O
C O
] O
palmitoyl O
- O
CoA O
binding O
of O
ACBP2 B
, O
an O
Arabidopsis O
acyl B
- I
CoA I
- I
binding I
protein I
with O
ankyrin B
repeats O
. O

Platelet B
- I
derived I
growth I
factor I
- O
dependent O
activation O
of O
phosphatidylinositol B
3 I
- I
kinase I
is O
regulated O
by O
receptor O
binding O
of O
SH2 B
- I
domain I
- I
containing I
proteins I
which O
influence O
Ras B
activity O
. O

Identification O
of O
a O
consensus O
cyclin B
- I
dependent I
kinase I
phosphorylation I
site I
unique O
to O
the O
nuclear O
form O
of O
human B
deoxyuridine I
triphosphate I
nucleotidohydrolase I
. O

Antimicrobial O
Susceptibility O
of O
Klebsiella O
pneumoniae O
Producing O
Extended B
- I
Spectrum I
beta I
- I
lactamase I
( O
ESBL B
) O
Isolated O
in O
Hospitals O
in O
Brazil O
. O

The O
LTR O
- O
binding O
activities O
of O
VBP B
, O
a1 B
/ I
EBP I
, O
and O
B B
- I
cell I
nuclear I
extract I
protein I
were O
compared O
and O
mapped O
by O
gel O
shift O
, O
DNase B
I I
footprinting O
, O
and O
methylation O
interference O
assays O
. O

In O
HCMV O
( O
Towne O
) O
- O
infected O
HF O
cells O
at O
24 O
to O
48 O
h O
, O
IE2 B
also O
accumulated O
in O
newly O
formed O
viral O
DNA O
replication O
compartments O
containing O
the O
polymerase B
processivity I
factor I
( O
UL44 B
) O
, O
the O
single B
- I
stranded I
DNA I
binding I
protein I
( O
SSB B
; O
UL57 B
) O
, O
the O
UL112 B
- I
113 I
accessory I
protein I
, O
and O
newly O
incorporated O
bromodeoxyuridine O
( O
BrdU O
) O
. O

Identification O
of O
mutations O
in O
the O
coding O
sequence O
of O
the O
proto B
- I
oncogene I
c I
- I
kit I
in O
a O
human O
mast O
cell O
leukemia O
cell O
line O
causing O
ligand O
- O
independent O
activation O
of O
c B
- I
kit I
product I
. O

The O
mouse B
M I
- I
lysozyme I
downstream I
enhancer I
has O
been O
previously O
characterized O
on O
several O
levels O
of O
gene O
regulation O
. O

C B
/ I
EBP I
alpha I
also O
activates O
the O
promoter O
of O
the O
rat B
class I
- I
I I
ADH I
gene I
in O
a O
sequence O
- O
specific O
manner O
[ O
Potter O
et O
al O
. O
, O
Arch O
. O

C B
/ I
EBP I
alpha I
also O
activates O
the O
promoter O
of O
the O
rat B
class I
- I
I I
ADH I
gene I
in O
a O
sequence O
- O
specific O
manner O
[ O
Potter O
et O
al O
. O
, O
Arch O
. O

Mutations O
in O
the O
nuclear B
gene I
CBP1 I
of I
Saccharomyces I
cerevisiae I
result O
in O
degradation O
of O
mitochondrially B
encoded I
cytochrome I
b I
( O
cob B
) O
RNA O
; O
thus O
, O
the O
cells O
are O
unable O
to O
respire O
. O

Monospecific O
antibodies O
raised O
against O
rat B
cytochrome I
P I
- I
450 I
1A1 I
recognized O
a O
protein O
in O
the O
hepatic O
microsomes O
of O
the O
double O
- O
crested O
cormorant O
, O
and O
also O
in O
those O
of O
the O
great O
blue O
heron O
( O
Ardea O
herodias O
) O
, O
using O
immunoblotting O
. O

The O
carboxyl O
- O
terminal O
CCCC O
module O
is O
structurally O
related O
to O
the O
DNA O
- O
binding O
domain O
of O
the O
erythroid B
transcription I
factor I
GATA I
- I
1 I
. O

Rice B
dwarf I
phytoreovirus I
segment I
S12 I
transcript I
is O
tricistronic O
in O
vitro O
. O

The O
other O
two O
clones O
, O
Ash B
- I
m I
and I
- I
s I
, O
had O
nucleotide O
sequences O
identical O
with O
Ash B
- I
l I
cDNA O
in O
the O
amino O
- O
terminal O
region O
. O

We O
have O
attempted O
to O
clone O
two O
recessive O
extragenic O
suppressors O
of O
such O
ts O
mutants O
( O
sdp1 B
for O
mutation B
pol3 I
- I
14 I
and O
sdp5 B
- I
1 I
for O
mutation B
pol3 I
- I
11 I
) O
by O
transforming O
thermoresistant O
haploid O
strains O
pol3 B
- I
14 I
sdp1 I
and O
pol3 B
- I
11 I
sdp5 I
- I
1 I
with O
wild O
- O
type O
genomic O
libraries O
in O
singlecopy O
or O
multicopy O
vectors O
. O

The O
gene O
encoding O
the O
receptor O
for O
macrophage B
colony I
- I
stimulating I
factor I
1 I
( O
CSF B
- I
1 I
) O
, O
the O
c B
- I
fms I
protooncogene I
, O
is O
selectively O
expressed O
in O
immature O
and O
mature O
mononuclear O
phagocytes O
and O
trophoblasts O
. O

The O
observed O
phenotypes O
may O
be O
explained O
by O
( O
i O
) O
a O
selective O
disruption O
of O
very B
- I
low I
- I
density I
lipoprotein I
secretion O
due O
to O
decreased O
expression O
of O
genes O
encoding O
apolipoprotein B
B I
and O
microsomal B
triglyceride I
transfer I
protein I
, O
( O
ii O
) O
an O
increase O
in O
hepatic O
cholesterol O
uptake O
due O
to O
increased O
expression O
of O
the O
major O
high B
- I
density I
lipoprotein I
receptor I
, O
scavenger B
receptor I
BI I
, O
and O
( O
iii O
) O
a O
decrease O
in O
bile O
acid O
uptake O
to O
the O
liver O
due O
to O
down O
- O
regulation O
of O
the O
major O
basolateral B
bile I
acid I
transporters I
sodium I

Xenopus B
homolog I
of I
the I
mos I
protooncogene I
transforms O
mammalian O
fibroblasts O
and O
induces O
maturation O
of O
Xenopus O
oocytes O
. O

The O
Drosophila B
melanogaster I
suppressor I
of I
sable I
gene I
, O
su B
( I
s I
) I
, O
encodes O
a O
novel O
, O
150 O
- O
kDa O
nuclear O
RNA O
binding O
protein O
, O
SU B
( I
S I
) I
, O
that O
negatively O
regulates O
RNA O
accumulation O
from O
mutant O
alleles O
of O
other O
genes O
that O
have O
transposon O
insertions O
in O
the O
5 O
' O
transcribed O
region O
. O

To O
determine O
whether O
vanadate O
could O
inhibit O
PEPCK B
gene I
transcription O
, O
a O
series O
of O
chimeric O
genes O
containing O
several O
deletions O
in O
the O
P B
- I
enolypyruvate I
carboxykinase I
promoter I
between O
- O
550 O
and O
- O
68 O
was O
linked O
to O
the O
structural O
genes O
for O
either O
amino B
- I
3 I
- I
glycosyl I
phosphotransferase I
( O
neo B
) O
or O
chloramphenicol B
acetyltransferase I
and O
introduced O
into O
hepatoma O
cells O
using O
three O
methods O
: O
( O
a O
) O
infection O
with O
a O
Moloney O
murine O
leukemia O
virus O
- O
based O
retrovirus O
, O
( O
b O

Its O
organization O
and O
regulation O
indicate O
that O
the O
S B
. I
pombe I
URA1 I
gene I
product I
appears O
very O
similar O
to O
the O
S B
. I
cerevisiae I
URA2 I
gene I
product I
. O

Its O
organization O
and O
regulation O
indicate O
that O
the O
S B
. I
pombe I
URA1 I
gene I
product I
appears O
very O
similar O
to O
the O
S B
. I
cerevisiae I
URA2 I
gene I
product I
. O

Insulin B
- I
like I
growth I
factor I
1 I
( O
IGF B
- I
1 I
) O
in O
burn O
patients O
. O

Southern O
blot O
analysis O
of O
genomic O
DNA O
from O
somatic O
cell O
hybrids O
showed O
that O
endothelial B
- I
TACC I
- I
related I
cDNA I
maps O
to O
chromosome O
10 O
. O

The O
paramyxovirus B
fusion I
( I
F I
) I
protein I
mediates O
membrane O
fusion O
. O

The O
cDNA O
segment O
is O
flanked O
by O
the O
immunoglobulin B
gene I
recombination I
signal I
sequences I
so O
that O
the O
cDNA O
segment O
can O
invert O
and O
the O
human B
IL I
- I
2R I
L I
chain I
is O
subsequently O
expressed O
under O
the O
control O
of O
the O
SV40 B
promoter I
. O

Sp1 B
and O
two O
Sp3 B
isoforms I
were O
detected O
as O
the O
primary O
cellular O
constituents O
of O
DNA O
- O
protein O
complexes O
formed O
with O
the O
NF B
- I
kappaB I
- I
proximal I
site I
. O

E2F1 B
- O
mediated O
transcriptional O
inhibition O
of O
the O
plasminogen B
activator I
inhibitor I
type I
1 I
gene I
. O

Its O
predicted O
amino O
acid O
sequence O
shows O
extensive O
homology O
to O
those O
of O
Drosophila B
hsp70 I
, O
trout B
hsp70 I
, O
Xenopus B
hsp70 I
, O
yeast B
hsp70 I
, O
and O
some O
homology O
to O
the O
heat B
- I
inducible I
dnaK I
gene I
product I
of O
Escherichia O
coli O
. O

Sterile O
mutants O
of O
Saccharomyces O
cerevisiae O
were O
isolated O
from O
alpha O
* O
cells O
having O
the O
a B
/ I
alpha I
aar1 I
- I
6 I
genotype O
( O
exhibiting O
alpha O
mating O
ability O
and O
weak O
a O
mating O
ability O
as O
a O
result O
of O
a O
defect O
in O
a1 B
- I
alpha I
2 I
repression O
) O
. O

The O
5 O
' O
- O
terminus O
of O
the O
p B
- I
gvpF I
- I
M I
mRNA I
was O
located O
169 O
nucleotides O
upstream O
of O
p B
- I
gvpF I
within O
p B
- I
gvpE I
. O

Furthermore O
, O
competitor O
containing O
the O
YY1 B
consensus I
sequence I
competed O
for O
protein B
B I
binding O
, O
whereas O
competitor O
containing O
a O
perfect O
yeast B
ABF I
- I
1 I
consensus I
sequence I
did O
not O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
400 O
WORDS O
) O

Mature O
mRNA O
for O
cytosolic B
phosphoenolpyruvate I
carboxykinase I
of I
the I
chicken I
is O
2 O
. O
8 O
kilobases O
in O
length O
, O
similar O
to O
that O
previously O
noted O
for O
mRNA O
coding O
for O
the O
same O
enzyme O
in O
the O
rat O
. O

Splicing O
of O
the O
K B
- I
SAM I
alternative O
exon O
of O
the O
fibroblast B
growth I
factor I
receptor I
2 I
gene I
is O
heavily O
dependent O
on O
the O
U O
- O
rich O
sequence O
IAS1 B
lying O
immediately O
downstream O
from O
its O
5 O
' O
splice O
site O
. O

Recently O
, O
an O
alternatively O
spliced O
form O
of O
c B
- I
myb I
- I
encoded I
mRNA I
has O
been O
identified O
in O
murine O
cells O
containing O
either O
normal O
or O
rearranged O
c B
- I
myb I
genes I
. O

Cyclin B
- I
dependent I
kinase I
- I
2 I
( O
Cdk2 B
) O
forms O
an O
inactive O
complex O
with O
cyclin B
D1 I
since O
Cdk2 B
associated O
with O
cyclin B
D1 I
is O
not O
phosphorylated O
by O
Cdk7 B
- O
cyclin B
- I
H I
. O

Overexpression O
of O
Trdpm1 B
in O
a O
dpm1 B
( I
+ I
) I
: O
: O
his7 B
/ I
dpm1 I
( I
+ I
) I
S O
. O
pombe O
diploid O
resulted O
in O
a O
4 O
- O
fold O
increase O
in O
specific O
DPM B
synthase I
activity O
. O

D5 B
/ I
D1 I
( I
CT I
) I
or O
D5 B
/ I
D1D I
( I
CT I
) I
tail O
substitution O
mutants O
displayed O
a O
rank O
order O
of O
potency O
and O
agonist O
affinities O
virtually O
mimicking O
wild B
- I
type I
( I
wt I
) I
D1 I
receptors I
, O
as O
indexed O
by O
both O
ligand O
binding O
and O
dopamine O
- O
stimulated O
cAMP O
accumulation O
assays O
, O
and O
, O
similar O
to O
wt O
D1 B
receptors I
, O
did O
not O
exhibit O
receptor O
constitutive O
activity O
or O
responsiveness O
to O
inverse O
agonists O
. O

D5 B
/ I
D1 I
( I
CT I
) I
or O
D5 B
/ I
D1D I
( I
CT I
) I
tail O
substitution O
mutants O
displayed O
a O
rank O
order O
of O
potency O
and O
agonist O
affinities O
virtually O
mimicking O
wild B
- I
type I
( I
wt I
) I
D1 I
receptors I
, O
as O
indexed O
by O
both O
ligand O
binding O
and O
dopamine O
- O
stimulated O
cAMP O
accumulation O
assays O
, O
and O
, O
similar O
to O
wt O
D1 B
receptors I
, O
did O
not O
exhibit O
receptor O
constitutive O
activity O
or O
responsiveness O
to O
inverse O
agonists O
. O

Peroxisome B
proliferator I
- I
activated I
receptors I
( O
PPAR B
) O
modulate O
transcription O
by O
binding O
to O
specific O
peroxisome O
proliferator O
- O
response O
elements O
( O
PPRE O
) O
through O
heterodimerization O
with O
the O
9 B
- I
cis I
retinoic I
acid I
receptor I
( O
RXR B
) O
. O

Mutational O
analyses O
have O
demonstrated O
the O
importance O
of O
sequences O
within O
the O
327 O
bp O
segment O
that O
contain O
a O
putative O
cyclic B
AMP I
responsive I
element I
binding I
protein I
( O
CREB B
) O
binding O
site O
for O
TGF B
- I
beta I
1 I
and O
PMA O
responsiveness O
and O
putative O
PU B
- I
1 I
and O
Sp1 B
binding I
sites I
for O
basal O
promoter O
activity O
. O

Pre B
- I
beta I
- I
1 I
lipoprotein I
and O
early O
detection O
of O
risk O
factors O
for O
coronary O
heart O
disease O
. O

Significantly O
, O
two O
proximal O
GATA B
- I
1 I
- I
binding I
sites I
( O
- O
118 O
/ O
- O
113 O
and O
- O
98 O
/ O
- O
93 O
) O
and O
a O
region O
located O
within O
- O
518 O
to O
- O
315bp O
of O
the O
mouse B
ALAS2 I
promoter I
were O
essential O
for O
transcriptional O
activation O
during O
chemically O
induced O
differentiation O
of O
MEL O
cells O
, O
implying O
their O
importance O
in O
conferring O
erythroid O
specificity O
to O
the O
ALAS2 B
transcriptional O
activation O
. O

Ligand O
- O
independent O
activation O
of O
platelet B
- I
derived I
growth I
factor I
receptor I
is O
a O
necessary O
intermediate O
in O
lysophosphatidic O
, O
acid O
- O
stimulated O
mitogenic O
activity O
in O
L O
cells O
. O

Regulation O
of O
Gax B
homeobox B
gene I
transcription O
by O
a O
combination O
of O
positive O
factors O
including O
myocyte B
- I
specific I
enhancer I
factor I
2 I
. O

A O
synthetic O
oligonucleotide O
containing O
the O
SRE O
sequence O
from O
the O
mouse B
c I
- I
fos I
gene I
promoter I
( O
- O
299 O
to O
- O
322 O
) O
was O
radioactively O
labeled O
, O
used O
as O
a O
probe O
for O
the O
mobility O
shift O
assay O
and O
Southwestern O
( O
DNA O
- O
protein O
) O
blotting O
, O
and O
also O
used O
for O
sequence O
- O
specific O
affinity O
chromatography O
. O

These O
results O
demonstrate O
the O
existence O
of O
different O
PI B
3 I
- I
kinase I
isoforms I
and O
define O
a O
family O
of O
genes O
encoding O
distinct O
PI B
3 I
- I
kinase I
catalytic I
subunits I
that O
can O
associate O
with O
p85 B
. O

Here O
we O
localize O
a O
transferable O
40 O
- O
amino O
acid O
region O
within O
the O
LBDs B
of O
RXR B
, O
RAR B
, O
TR B
, O
and O
chicken B
ovalbumin I
upstream I
promoter I
transcription I
factor I
that O
is O
critical O
for O
determining O
identity O
in O
the O
heterodimeric O
interaction O
and O
for O
high O
- O
affinity O
DNA O
binding O
. O

It O
is O
present O
in O
the O
nucleus O
of O
the O
cells O
in O
which O
it O
is O
expressed O
and O
can O
phosphorylate O
and O
activate O
the O
cyclic B
AMP I
response I
element I
binding I
proteins I
CREB B
and O
CREM B
tau I
in O
a O
manner O
analogous O
to O
protein B
kinase I
A I
. O

We O
conclude O
that O
c B
- I
Myb I
regulates O
the O
RAG B
- I
2 I
promoter I
in O
T O
cells O
by O
binding O
to O
this O
consensus B
c I
- I
Myb I
binding I
site I
. O

ENV B
also O
was O
secreted O
from O
P O
. O
pastoris O
using O
the O
S B
. I
cerevisiae I
alpha I
- I
factor I
prepro I
secretion I
leader I
and O
the O
S B
. I
cerevisiae I
invertase I
signal I
sequence I
. O

The O
nucleotide O
sequences O
of O
the O
human B
and I
murine I
ornithine I
decarboxylase I
mRNAs I
share O
an O
85 O
% O
homology O
, O
even O
in O
their O
3 O
' O
- O
noncoding O
regions O
. O

Analysis O
of O
the O
protein O
sequences O
of O
these O
two O
replicases B
, O
together O
with O
previously O
characterized O
H B
. I
pylori I
plasmid I
replication I
proteins I
, O
supports O
the O
formation O
of O
a O
distinct O
class O
of O
H B
. I
pylori I
plasmid I
proteins I
. O

Interleukin B
- I
8 I
( O
IL B
- I
8 I
) O
is O
a O
potent O
inflammatory O
mediator O
that O
belongs O
to O
the O
family O
of O
C B
- I
X I
- I
C I
chemokines I
. O

Deletion O
analysis O
of O
rOC B
promoter I
- O
chloramphenicol B
acetyltransferase I
constructs O
demonstrates O
that O
an O
AML B
- I
1 I
- I
binding I
sequence I
within O
the O
proximal O
promoter O
( O
- O
138 O
to O
- O
130 O
nt O
) O
contributes O
to O
75 O
% O
of O
the O
level O
of O
osteocalcin B
gene I
expression O
. O

In O
addition O
, O
a O
noncanonical O
C B
/ I
EBP I
- I
binding I
site I
within O
the O
Gadd45gamma B
promoter I
where O
C B
/ I
EBPbeta I
and O
C B
/ I
EBPdelta I
could O
bind O
, O
was O
identified O
by O
electrophoretic O
mobility O
shift O
assay O
( O
EMSA O
) O
and O
reporter O
gene O
analysis O
. O

Although O
both O
transfected O
cell O
lines O
contain O
FGF B
- I
1 I
cell I
surface I
receptors I
as O
judged O
by O
crosslinking O
studies O
, O
the O
wild O
- O
type O
transfectants O
are O
refractory O
to O
exogenous O
FGF B
- I
1 I
, O
whereas O
the O
mutant O
transfectants O
respond O
normally O
. O
( O
ABSTRACT O
TRUNCATED O
AT O
250 O
WORDS O
) O

